ClinConnect ClinConnect Logo
Search / Trial NCT06764108

Multimodality Adaptive Intervention for Post-Inpatient Hospitalization Suicide Risk Reduction

Launched by MASSACHUSETTS GENERAL HOSPITAL · Jan 2, 2025

Trial Information

Current as of November 14, 2025

Not yet recruiting

Keywords

Just In Time Adaptive Intervention Jitai Micro Randomized Trial Mrt Sequential Multiple Assignment Randomized Trial Smart Single Session Intervention Ssi Hybrid Experimental Design

ClinConnect Summary

This clinical trial is looking at ways to help adults who have recently been in the hospital for suicidal thoughts or attempts. The main goal is to see if a combination of quick digital messages sent to their smartphones and extra sessions with a clinician can help these individuals manage their feelings and reduce the risk of suicide. The study will compare people who receive just self-monitoring on their phones with those who also get helpful reminders and support from a clinician.

To participate in the trial, you need to be at least 18 years old, own a smartphone, and have been hospitalized due to suicidal thoughts or attempts. If you join, you will create a personalized safety plan before leaving the hospital, track your thoughts and feelings on your smartphone for four weeks, and fill out some questionnaires during that time. Depending on which group you are placed in, you may receive automated messages, extra sessions with a clinician, or self-guided online tools to help you cope. The study is not yet recruiting participants, but it aims to gather important information to better support individuals at risk for suicide.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult status (18+ years-old)
  • Ownership of a smartphone (iOS or Android)
  • Inpatient admission due to suicidal thoughts or suicide attempt
  • Exclusion Criteria:
  • - Presence of any factor that impairs an individual's ability to comprehend and effectively participate in the study, including an inability to speak or write English fluently, the presence of gross cognitive impairment due to florid psychosis, intellectual disability, dementia, acute intoxication, or the presence of extremely agitated or violent behavior

About Massachusetts General Hospital

Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported